AffordableGLP-1Providers Take the quiz
Tool · endpoints only

The timeline, at trial honesty

Released: · Last reviewed:

Most "timeline" tools draw smooth curves nobody measured. This one shows only published endpoints from the pivotal brand trials, applied to your starting weight — with the caveats that make the number mean something: brand products, supervised trials, maximum tolerated doses, wide individual variation, and months of titration before full dose.

Early months are titration: doses start low and step up every 4 weeks, so trial-average loss is not linear and the first weeks are typically modest.

−46 lbat 72 weeks, if your response matched the SURMOUNT-1 average

Averages hide a spread: substantial numbers of participants lost much more and much less.

Endpoints: SURMOUNT-1 (NEJM 2022), STEP-1 (NEJM 2021) — brand products; compounded versions have no equivalent trial data. This tool is informational only and is not medical advice; decisions about medication, dosing, and diet belong with a licensed clinician who knows your history.

Researched By

Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.